Category: Life Sciences
North America Life Sciences
-
Clinical Rollators
... CAGR of 5.0% over the analysis period 2024-2030. 4-Wheeler Rollators, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$262.0 Million by the end of the analysis ... Read More
-
Flavored Syrups
... CAGR of 4.4% over the analysis period 2024-2030. Fruit Flavor, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$24.1 Billion by the end of the analysis ... Read More
-
Garden Tools
... CAGR of 4.9% over the analysis period 2024-2030. Pruning Tools, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$50.8 Billion by the end of the analysis ... Read More
-
Gaucher Disease Treatment
... at a CAGR of 3.8% over the analysis period 2024-2030. Enzyme Replacement Therapy, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.7 Billion by the end ... Read More
-
Gensets
... 5.6% over the analysis period 2024-2030. Diesel Gensets, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$25.1 Billion by the end of the analysis period. Growth ... Read More
-
Business Jets
... CAGR of 5.2% over the analysis period 2024-2030. Large Jets, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$19.8 Billion by the end of the analysis ... Read More
-
Urgent Care Center
... at a CAGR of 6.0% over the analysis period 2024-2030. Trauma / Injury Treatment, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$12.2 Billion by the ... Read More
-
Nasal Splints
... CAGR of 4.1% over the analysis period 2024-2030. Intranasal Splints, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Endometrial Ablation Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More
-
Healthcare Cleanroom Consumables
... at a CAGR of 4.8% over the analysis period 2024-2030. Cleanroom Apparels, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.7 Billion by the end of ... Read More
-
Transcatheter Heart Valves
... at a CAGR of 16.6% over the analysis period 2024-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$31.4 Billion by the ... Read More
-
Vancomycin
... 4.9% over the analysis period 2024-2030. Lung Infection, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis period. Growth ... Read More
-
Antisense and RNAi Therapeutics
... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Antisense RNA, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.8 Billion by the ... Read More
-
Soldier Systems
... CAGR of 4.8% over the analysis period 2024-2030. Personal Protection, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$3.8 Billion by the end of the analysis ... Read More
-
Generic Drugs
... CAGR of 6.5% over the analysis period 2024-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of the analysis ... Read More
-
Intracranial Aneurysm
... CAGR of 8.7% over the analysis period 2024-2030. Endovascular Coiling, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Local Anesthesia Drugs
... at a CAGR of 5.1% over the analysis period 2024-2030. Lidocaine, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Probiotics Dietary Supplements
... at a CAGR of 5.8% over the analysis period 2024-2030. Capsules, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.2 Billion by the end of the ... Read More
-
Prostate Cancer Diagnostics
... at a CAGR of 13.3% over the analysis period 2024-2030. Preliminary, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$10.0 Billion by the end of the ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical), one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 Billion ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
Radiopharmaceuticals
... 11.0% over the analysis period 2024-2030. Oncology, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$6.9 Billion by the end of the analysis period. Growth in ... Read More
-
Computer Aided Detection (CAD)
... 2030, growing at a CAGR of 9.1% over the analysis period 2024-2030. Mammography, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$759.0 Million by the end ... Read More
-
Healthcare Distribution
... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis period. ... Read More
-
Microelectronic Medical Implants
... at a CAGR of 8.0% over the analysis period 2024-2030. Pacemakers & Defibrillators, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$22.7 Billion by the end ... Read More
Research Assistance
